Webinar | Sodium Reduction Solutions That Pass The Cost, Safety, And Consumer Test: Register Now

Centivax

Centivax is a biotechnology company that develops vaccines and therapeutic antibodies targeting infectious diseases and venomous threats.
2020
11 – 50
South San Francisco, California, United States

Investment Funding

Last Funding Stage

Early Stage Venture

Total Funding Amount

$59.2M

Last Funding Amount

$45.0M

Last Funding Date

08-07-2025

Startup Stage

Series A

Lead Investors

Future Ventures, Global Health Investment Corporation, Henry M. Jackson Foundation, NFX

Revenue

$1M to $10M

People

Founders

Something missing or incorrect on this page? Help us enrich this information